Your browser doesn't support javascript.
Reply to 'development of severe pemphigus vulgaris following SARS-CoV-2 vaccination with BNT162b2' by Solimani F et al.
Falcinelli, F; Lamberti, A; Cota, C; Rubegni, P; Cinotti, E.
  • Falcinelli F; Dermatology Unit and Skin Bank, Department of Medical, Surgical and Neurosciences, Siena University Hospital, Siena, Italy.
  • Lamberti A; Dermatology Unit and Skin Bank, Department of Medical, Surgical and Neurosciences, Siena University Hospital, Siena, Italy.
  • Cota C; Dermatopathology Unit, San Gallicano Dermatological Institute, IRCCS, Rome, Italy.
  • Rubegni P; Dermatology Unit and Skin Bank, Department of Medical, Surgical and Neurosciences, Siena University Hospital, Siena, Italy.
  • Cinotti E; Dermatology Unit and Skin Bank, Department of Medical, Surgical and Neurosciences, Siena University Hospital, Siena, Italy.
J Eur Acad Dermatol Venereol ; 36(12): e976-e978, 2022 12.
Article in English | MEDLINE | ID: covidwho-1916193

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pemphigus / COVID-19 Topics: Vaccines Limits: Humans Language: English Journal: J Eur Acad Dermatol Venereol Journal subject: Dermatology / Sexually Transmitted Diseases Year: 2022 Document Type: Article Affiliation country: Jdv.18398

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Pemphigus / COVID-19 Topics: Vaccines Limits: Humans Language: English Journal: J Eur Acad Dermatol Venereol Journal subject: Dermatology / Sexually Transmitted Diseases Year: 2022 Document Type: Article Affiliation country: Jdv.18398